GLAXF - Trade Savi - 360-degree view on crypto market

GLAXF GSK

Shares of GSK down as weak vaccine sales cast shadow on earnings beat

GSK shares dropped over 3% after disappointing Q3 2024 earnings, driven by lackluster vaccine sales and uncertain future growth despite maintaining EPS guidance.

investing.com • 30/10/2024 - 11:44 AM

Greed and Fear Index

Note: The data is for reference only.

Extreme Greed

Shares of GSK down as weak vaccine sales cast shadow on earnings beat

Greed and Fear Index

Currency